Rahul Purwar
Mumbai, MH, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Enabling access to talicabtagene autoleucel in relapsed/refractory B-cell malignancies; multicenter real-world evidence on delivery, efficacy and safety.
Journal: Blood cancer journal
Published: February 24, 2026
Molecular Profiling of Belumosudil-Treated IOMM-Lee Meningioma Cells Reveals Repurposing Potential via Enhanced Oxidative Phosphorylation and ROS-Mediated Cell Death.
Journal: Journal of proteome research
Published: September 13, 2025
Quantitative Proteomic Analysis Reveals JMJD6 and DNAJB11 as Endogenous Substrates of E3 Ligase RFFL.
Journal: Journal of proteome research
Published: June 26, 2025
Mass spectrometry-based proteomics in glioblastoma - current understanding and future impact.
Journal: Brain research
Published: May 27, 2025
Correction: Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib study.
Journal: Blood cancer journal
Published: May 20, 2025
Implementation of a CAR-T cell therapy program in India.
Journal: Expert review of anticancer therapy
Published: May 08, 2025
Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib study.
Journal: Blood cancer journal
Published: December 17, 2024
IL-9 Promotes Migratory Dissemination of Malignant T Cells by Activating the HIF-1α-Cofilin-1 Axis in Cutaneous T-cell Lymphoma.
Journal: Molecular cancer research : MCR
Published: October 30, 2024
Talicabtagene autoleucel for relapsed or refractory B-cell malignancies: results from an open-label, multicentre, phase 1/2 study.
Journal: The Lancet. Haematology
Published: October 23, 2024
CAR-T cell therapy in hematological malignancies: Where are we now and where are we heading for?
Journal: European journal of haematology
Published: June 02, 2023
IL-17A Orchestrates Reactive Oxygen Species/HIF1α-Mediated Metabolic Reprogramming in Psoriasis.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: May 10, 2023
Oncolytic immunovirotherapy for high-grade gliomas: A novel and an evolving therapeutic option.
Journal: Frontiers in immunology
Published: December 07, 2022
Last Updated: 09/26/2026